Search results
Pfizer sued by Kansas for allegedly hiding COVID vaccine risks, making false claims
NY Post via Yahoo News· 1 day agoThe lawsuit claims that, beginning shortly after the vaccine's rollout in early 2021, Pfizer...
Kansas sues Pfizer over 'misrepresentations' and 'adverse events' of COVID-19 vaccine
FOX Business· 1 day agoThe State of Kansas has filed a lawsuit against Pfizer, Inc. for alleged consumer protection...
Kansas Attorney General Kris Kobach sues Pfizer over marketing of COVID-19 vaccine
Wichita Eagle via Yahoo News· 1 day ago“We are proud to have developed the COVID-19 vaccine in record time in the midst of a global...
Kansas sues Pfizer, saying it misled the public over COVID-19 vaccine
Market Watch· 17 hours agoIn a lawsuit filed on Monday, the U.S. state alleges Pfizer made false statements about the safety...
Kansas AG joins with Texas to become second state to sue Pfizer over COVID-19 vaccine
BizPac Review· 10 hours agoKansas Attorney General Kris Kobach announced on Monday that he was suing the pharmaceutical company Pfizer over the COVID-19 vaccine ...
Kansas sues Pfizer over COVID vaccine for what Kris Kobach calls 'misleading marketing'
The Topeka Capital-Journal via Yahoo News· 1 day agoSauer gained national attention when arguing in a federal appellate court that presidential immunity...
Kobach sues Pfizer over COVID vaccine claims
KSNW Wichita via Yahoo News· 1 day agoKansas Attorney General Kris Kobach has filed a lawsuit against Pfizer. He says the company made misleading and deceptive claims about its COVID-19 ...
Gateway - Quartz
Quartz· 1 hour agoThe company announced on Oct. 20 that it intends to sell the covid vaccine, marketed under the brand name Comirnaty, for $110 to $130 per dose. According ...
Kansas attorney general sues Pfizer over COVID vaccine, company responds
KSNT Topeka· 1 day agoRelated video: Class action lawsuits – what are they, and should you join one? TOPEKA (KSNT) –...
Novavax Seeks FDA Nod for Updated COVID-19 Vaccine - Novavax (NASDAQ:NVAX), Moderna (NASDAQ:MRNA)
Benzinga· 9 hours agoNovavax's filing is based on guidance from the FDA issued last week, which advised COVID-19 vaccine...
